SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

Table of Contents

offering would decrease the pro forma as adjusted net tangible book value per share after this offering by $             and increase the dilution per share to new investors participating in this offering by $             , assuming no change in the assumed initial public offering price per share and after deducting the estimated underwriting discounts and commissions.

          If the underwriters exercise their option to purchase additional shares of our common stock in full, the pro forma as adjusted net tangible book value after this offering would be $             per share, the increase in pro forma net tangible book value per share would be $             and the dilution per share to new investors would be $             per share, in each case assuming an initial public offering price of $             per share, which is the midpoint of the price range set forth on the cover page of this prospectus.

          The following table summarizes, as of September 30, 2015 on the pro forma as adjusted basis described above, the differences between the number of shares purchased from us, the total consideration paid to us in cash and the average price per share that existing stockholders and new investors paid for such shares. The calculation below is based on an assumed initial public offering price of $             per share, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 
  Shares
Purchased
  Total
Consideration
   
 
 
 
Average
Price
Per Share
 
 
 
Number
 
Percent
 
Amount
 
Percent
 

Existing stockholders

                        % $                     % $                

New investors

                               

Total

                      100 %         100 %      

          The foregoing tables and calculations are based on the number of shares of our common stock outstanding as of September 30, 2015, after giving effect to the automatic conversion of all outstanding shares of our preferred stock into common stock upon the closing of this offering, and exclude:

    1,268,691 shares of common stock issued pursuant to a restricted stock purchase agreement that are subject to repurchase as of September 30, 2015;

    1,147,479 shares of common stock issuable upon the exercise of outstanding stock options as of September 30, 2015, at a weighted-average exercise price of $19.31 per share;

    236,636 shares of common stock issuable upon the exercise of outstanding warrants as of September 30, 2015, at a weighted-average exercise price of $3.55 per share, which warrants are expected to remain outstanding at the consummation of this offering;

    up to a maximum of 307,922 shares of common stock reserved for future issuance under the 2014 Plan as of September 30, 2015; and

                 shares of our common stock reserved for future issuance under our 2016 Plan, which will become effective upon the signing of the underwriting agreement in connection with this offering, as well as any automatic increases in the number of shares of common stock reserved for future issuance under the 2016 Plan.

          To the extent any of these outstanding options and warrants are exercised and the shares of restricted stock vest, there will be further dilution to new investors. If all of such outstanding options and warrants had been exercised and all of such restricted stock vested as of September 30, 2015,

80



© AveXis, Inc. All Rights Reserved.